Millington Securities’s Virtus Biotech ETF BBP Stock Holding History

Millington Securities’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32M	Buy	+15,894	New	+$1.31M	0.36%	60

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millington Securities's BBP Position: Q1 2026 in Review

Millington Securities opened a new position in Virtus Biotech ETF (BBP) in Q1 2026: 15,894 shares worth $1.32M. The stake represents 0.36% of the portfolio and ranks #60 among its holdings.

26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

Millington Securities held 15,894 shares of Virtus Biotech ETF worth $1.32M as of Q1 2026.
Virtus Biotech ETF was a new Millington Securities position in Q1 2026.
Virtus Biotech ETF made up 0.36% of Millington Securities's portfolio in Q1 2026, its #60 holding.
26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Millington Securities's 13F filing for Q1 2026, filed 15 Jul 2026.